PRIMR

PRIMR PRIMR creates simple illustrated videos to educate patients about cancer and clinical trials.

The American Society of Clinical Oncology (ASCO) fuels next-gen therapies.On Day 5 of , we're featuring the SAMURAI tr...
06/02/2026

The American Society of Clinical Oncology (ASCO) fuels next-gen therapies.

On Day 5 of , we're featuring the SAMURAI trial, testing stereotactic ablative radiotherapy plus immunotherapy in unresected metastatic RCC to improve outcomes.

Watch the IRB-approved video:
https://www.primrmed.com/cancer-clinical-trials/samurai-trial

Produced in collaboration with NRG Oncology | William A. Hall, MD | Rana McKay.

The American Society of Clinical Oncology (ASCO) expands options for targeted neuro-oncology care.On Day 5 of , we're ...
06/02/2026

The American Society of Clinical Oncology (ASCO) expands options for targeted neuro-oncology care.

On Day 5 of , we're featuring the FRONTIER study, evaluating Yttrium-90 internal radiation for recurrent GBM.

Watch the IRB-approved video:
https://www.primrmed.com/cancer-clinical-trials/frontier-trial

Produced in collaboration with Boston Scientific Urology | Boston Scientific Peripheral Interventions | Boston Scientific Urology .

The American Society of Clinical Oncology (ASCO) champions treatment that protects quality of life.On Day 4 of , we're...
06/01/2026

The American Society of Clinical Oncology (ASCO) champions treatment that protects quality of life.

On Day 4 of , we're spotlighting the IRRADIANT trial, comparing a new IRE boost to standard RT for intermediate-risk prostate cancer to evaluate efficacy and toxicities.

Watch the IRB-approved video:
https://www.primrmed.com/cancer-clinical-trials/irradiant

Produced in collaboration with Memorial Sloan Kettering Cancer Center | Himanshu Nagar | AngioDynamics | The Nano Knife System.

The American Society of Clinical Oncology (ASCO) is redefining the standards of combination therapy. On Day 4 of , we'...
06/01/2026

The American Society of Clinical Oncology (ASCO) is redefining the standards of combination therapy.

On Day 4 of , we're sharing the STRIKE trial, testing if adding tivozanib to pembrolizumab reduces recurrence for advanced kidney cancer after surgery or ablation.

Watch the IRB-approved video:
https://www.primrmed.com/cancer-clinical-trials/strike

Produced in collaboration with the Alliance for Clinical Trials in Oncology | AVEO Oncology.

The American Society of Clinical Oncology (ASCO) is paving the way for breakthroughs in cancer detection.On Day 3 of ,...
05/31/2026

The American Society of Clinical Oncology (ASCO) is paving the way for breakthroughs in cancer detection.

On Day 3 of , we're highlighting the AMPLIFY Trial, testing a new PSMA PET tracer to better detect prostate cancer recurrence.

Watch the IRB-approved video:
https://www.primrmed.com/cancer-clinical-trials/amplify-trial

Produced in collaboration with Clarity Pharmaceuticals.

The American Society of Clinical Oncology (ASCO) is redefining treatment standards.On Day 3 of , we’re featuring ARCHE...
05/31/2026

The American Society of Clinical Oncology (ASCO) is redefining treatment standards.

On Day 3 of , we’re featuring ARCHER, testing shorter SBRT vs standard radiation with chemo for bladder cancer to preserve the organ and protect quality of life.

Watch the IRB-approved video:
https://www.primrmed.com/cancer-clinical-trials/archer

Produced in partnership with NRG Oncology | Himanshu Nagar | Natera .

The American Society of Clinical Oncology (ASCO) is redefining what's possible in clinical oncology.On Day 2 of , we’...
05/30/2026

The American Society of Clinical Oncology (ASCO) is redefining what's possible in clinical oncology.

On Day 2 of , we’re spotlighting METANOVA, a trial evaluating the impact of adding metastasis-directed radiotherapy in oligometastatic prostate cancer.

Watch the IRB-approved video:
https://www.primrmed.com/cancer-clinical-trials/stampede2

Produced in collaboration with University Hospitals | Case Comprehensive Cancer Center.

The American Society of Clinical Oncology (ASCO) is where global research transforms patient care.On Day 2 of , we’re ...
05/30/2026

The American Society of Clinical Oncology (ASCO) is where global research transforms patient care.

On Day 2 of , we’re featuring the Alliance for Clinical Trials in Oncology Lung NETs Study, testing if Lu-177 dotatate can outperform the currently sole approved option, everolimus, for better control of advanced lung NETs.

Watch the IRB-approved video:
https://www.primrmed.com/cancer-clinical-trials/alliance-lung-nets

Produced in collaboration with the Alliance for Clinical Trials in Oncology.

The American Society of Clinical Oncology (ASCO) is bridging the gap between clinical innovation and patient outcomes.O...
05/29/2026

The American Society of Clinical Oncology (ASCO) is bridging the gap between clinical innovation and patient outcomes.

On Day 1 of , we’re featuring the ESCAPE trial, assessing PSMA PET imaging’s role in active surveillance for prostate cancer.

Watch the IRB-approved video:
https://www.primrmed.com/cancer-clinical-trials/escape-trial

Produced in collaboration with Weill Cornell Medicine.

Address

Hartford, CT
06117

Website

Alerts

Be the first to know and let us send you an email when PRIMR posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share

Category